| Literature DB >> 16651401 |
Knut Kotarsky1, Ake Boketoft, Jesper Bristulf, Niclas E Nilsson, Ake Norberg, Stefan Hansson, Christer Owman, Rannar Sillard, L M Fredrik Leeb-Lundberg, Björn Olde.
Abstract
Here, the ligand binding, activation, and tissue distribution of the orphan G protein-coupled receptor (GPCR) GPR92 were studied. GPR92 binds and is activated by compounds based on the lysophosphatidic acid (LPA) backbone. The binding of LPA to GPR92 was of high affinity (K(D) = 6.4 +/- 0.9 nM) and led to an increase in both phosphoinositide hydrolysis and cAMP production. GPR92 is atypical in that it has a low sequence homology with the classic LPA(1-3) receptors (21-22%). Expression of GPR92 is mainly found in heart, placenta, spleen, brain, lung, and gut. Notably, GPR92 is highly expressed in the lymphocyte compartment of the gastrointestinal tract. It is the most abundant GPCR activated by LPA found in the small intestinal intraepithelial CD8+ cytotoxic T cells.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16651401 DOI: 10.1124/jpet.105.098848
Source DB: PubMed Journal: J Pharmacol Exp Ther ISSN: 0022-3565 Impact factor: 4.030